A double blind randomised placebo controlled clinical trial for evaluating the efficacy of Eranda Patra Kshara and Hingu churna with lifestyle modification in the management of Non-alcoholic fatty liver disease

A double blind randomised placebo controlled clinical trial for evaluating the efficacy of Eranda Patra Ksharaand Hingu churna along with lifestyle modification in the management of Non-alcoholic fatty liver disease

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/04/052096

Enrollment

Registered

2023-04-28

Start date

Unknown

Completion date

Unknown

Last updated

2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Non-alcoholic fatty liver disease

Exclusion criteria

Exclusion criteria: 1.The ratio of AST/ALT over 2 2.Metabolic syndrom such as uncontrolled Type 1 and Type 2 diabetes mellitus,hypertension 3.Thyroid dysfunction hyperthyroidism or hypothyroidism. 4.Alcoholic fatty liver disease patient

Design outcomes

Primary

Measure	Time frame
Changes in the infiltration of fat globules in the USG findings along with changes in clinical presentations. Changes in FibroscanTimepoint: 15th day , 30th days	—

Secondary

Measure	Time frame
Liver Function Test Lipid profile Improvement in body weight and BMI Overall improvement in quality of lifeTimepoint: 15th day , 30th days	—

Countries

India

Contacts

Public ContactDrMohammad Uvaish

All India Institute of Aurveda

drvghuddar@gmail.com9986697942

Outcome results